The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
Open Access
- 3 March 2017
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 14 (1) , 1-6
Abstract
Despite availability of annual influenza vaccines, influenza causes significant morbidity and mortality in the elderly. This is at least in part a result of immunosenescence; the age-dependent decrease in immunological competence that results in greater susceptibility to infections and reduced responses to vaccination. To improve protective immune responses in this age group, new vaccines strategies, such as the use of adjuvants, are needed. Here, we evaluated the mucosal vaccine adjuvant Endocine™, formulated with split influenza antigen and administered intranasally in aged (20-month old) mice. Humoral immune responses were assessed and compared to unadjuvanted intranasal and subcutaneous vaccines. We show that formulation with Endocine™ significantly enhances hemagglutination inhibition (HI) titers, as well as serum IgG and mucosal IgA antibody titers, compared to both types of unadjuvanted vaccines. Thus, our results indicate that intranasal vaccination with Endocine™ is a possible approach for the development of mucosal influenza vaccines for the elderly.Keywords
This publication has 31 references indexed in Scilit:
- Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza VaccinationPLOS ONE, 2013
- Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approachExpert Review of Vaccines, 2012
- A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in agingVaccine, 2012
- Influenza vaccine responses in older adultsAgeing Research Reviews, 2011
- Aging impacts isolated lymphoid follicle development and functionImmunity & Ageing, 2011
- The Eurocine® L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccinationVaccine, 2010
- Impaired immune responses in the lungs of aged mice following influenza infectionRespiratory Research, 2009
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesNew England Journal of Medicine, 2009
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Aging‐Associated Changes in Murine Intestinal Immunoglobulin A and M SecretionsScandinavian Journal of Immunology, 1988